Immunohistochemistry Assay, Antibody, Claudin 18
QZJ is the FDA product code for Immunohistochemistry Assay, Antibody, Claudin 18, a class III device type, regulated under 21 CFR 864.1860. FDA's definition for this code reads: "The Claudin 18 antibody is a qualitative immunohistochemical antibody intended to identify CLDN18 protein expression in human clinical tissue specimens. The CLDN18 antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- QZJ
- Device name
- Immunohistochemistry Assay, Antibody, Claudin 18
- FDA definition
- The Claudin 18 antibody is a qualitative immunohistochemical antibody intended to identify CLDN18 protein expression in human clinical tissue specimens. The CLDN18 antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs.
- Regulation
- 21 CFR 864.1860
- Device class
- Class III
- Review panel
- Hematology
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
